Avalanche Treasury Corp (MASI) is a Financials stock trading at $0.34 (as of 2026-08-12), with a market capitalization of $9.91M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Masimo develops, manufactures, and sells noninvasive monitoring technologies and hospital automation solutions, and it makes money by selling its signal extraction technology (SET) pulse oximetry and its Masimo rainbow SET platform, including pulse CO-Oximetry products that noninvasively monitor multiple parameters.
Masimo's profit engine is tied to expanding hospital adoption, shown by incremental value from new healthcare contracts and a large HEOS installed base, which then supports ongoing technology and consumable usage.
| Healthcare | $0.4B |
Business quality (Weak): Differentiated noninvasive monitoring features (including measure-through motion and low perfusion performance) and a sizable installed base are positives, but the company also shows technology and consumable revenue declines that could pressure growth.
Valuation: At 127× earnings, MASI trades 291% above the Medical Equipment average (32×). Note: one-time items can distort reported P/E.
| Price | $0.34 |
| Market Cap | $9.91M |
| Price / Book | 0.12 |
| Return on Equity | -53.3% |
| Current Ratio | 11.18 |
| Sector P/E (Financials) | 15.1 |
| Industry P/E (Banking) | 12.9 |
| Sector | Financials |
| Industry | Banking |
Data as of 2026-08-12.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.